Leadership Overview
Commonwealth Fusion Systems has 5 executives leading key functions including strategy, operations, finance, legal, and people.
Driven by scientific integrity, Commonwealth Fusion Systems is dedicated to developing economically viable fusion energy solutions, aiming to deliver clean, abundant energy and combat climate change through innovative tokamak systems.
Driven by scientific integrity, Commonwealth Fusion Systems is dedicated to developing economically viable fusion energy solutions, aiming to deliver clean, abundant energy and combat climate change through innovative tokamak systems.
Leadership Roles at Commonwealth Fusion Systems
Robert Mumgaard - Co-Founder & Chief Executive Officer
Robert Mumgaard, the Co-Founder & Chief Executive Officer at Commonwealth Fusion Systems, directs the company's overarching strategy and vision for commercial fusion energy. Mumgaard architects the development of high-temperature superconducting magnets, essential for creating smaller, cost-effective tokamak fusion systems. This leadership role involves guiding the manufacturing of the SPARC machine, targeting net energy fusion, and paving the path for the ARC fusion power plant. Overseeing global collaborations with suppliers and researchers, Robert Mumgaard ensures the delivery of clean, abundant energy solutions to combat climate change. The Chief Executive Officer's focus remains on scientific integrity and the creation of economically viable fusion energy, driving the company's mission forward.

Mitchell Goldstein - Chief Financial Officer
Mitchell Goldstein, the Chief Financial Officer at Commonwealth Fusion Systems, directs all financial planning, investment strategies, and fiscal management for the company's fusion energy ventures. Goldstein oversees the allocation of capital towards the development of advanced tokamak systems and the manufacturing of the SPARC machine, ensuring financial sustainability. This executive function is vital for securing funding and managing the economic aspects of creating commercially relevant net energy fusion devices. The Chief Financial Officer analyzes market opportunities and financial risks associated with global clean energy initiatives. By maintaining robust financial controls and driving fiscal discipline, Mitchell Goldstein supports the company's mission to deliver economically viable fusion power and combat climate change.
Julian Soell - Chief Operating Officer
Julian Soell, the Chief Operating Officer at Commonwealth Fusion Systems, manages the day-to-day operational execution of the company's fusion energy development initiatives. Soell oversees the complex manufacturing processes for the SPARC machine, ensuring efficient production and adherence to stringent quality standards. This operational leadership is critical for scaling the company's innovative tokamak systems and high-temperature superconducting magnets. The Chief Operating Officer coordinates internal resources and external partnerships to support the company's mission of delivering clean, abundant energy. By optimizing production workflows and supply chain logistics, Julian Soell directly contributes to the economic viability and timely deployment of fusion power solutions.
David Tressler - Chief Legal Officer
David Tressler, the Chief Legal Officer at Commonwealth Fusion Systems, provides strategic legal counsel and oversees all legal affairs pertaining to the company's fusion energy technology development. Tressler manages intellectual property portfolios for high-temperature superconducting magnets and tokamak systems, safeguarding innovation. This role is critical for navigating regulatory landscapes and ensuring compliance in the pursuit of commercial fusion power. The Chief Legal Officer advises on contractual agreements with global suppliers and research partners, facilitating collaboration. By mitigating legal risks and ensuring adherence to corporate governance, David Tressler supports the company's mission to deliver clean, abundant energy solutions and advance the development of economically viable fusion power plants.
Alex Mozdzanowska - Chief People Officer
Alex Mozdzanowska, the Chief People Officer at Commonwealth Fusion Systems, leads human capital strategy, talent acquisition, and organizational development to support the company's ambitious fusion energy goals. Mozdzanowska cultivates a mission-driven culture focused on scientific integrity and innovation, essential for attracting and retaining top talent in the specialized field of fusion energy. This executive function is key to building a high-performing team capable of developing advanced tokamak systems and superconducting magnets. The Chief People Officer oversees employee engagement, professional development, and diversity initiatives, fostering an environment conducive to groundbreaking research. By championing the company's values and ensuring a supportive workplace, Alex Mozdzanowska directly contributes to the successful realization of economically viable fusion power.
Explore Leadership Teams in Business Services
Founded in 1986, AmSpec is headquartered in Cranbury, New Jersey. They provide inspection and testing services to multiple sectors of the agricultural, oil and petrochemical industries.
Company Leadership
SD
DN
GO
Nova Biomedical is a privately held medical device company headquartered in Waltham, Massachusetts, specializing in the development, manufacturing, and commercialization of advanced analytical instruments and consumables for the biopharmaceutical and clinical markets. Renowned for its innovative in vitro diagnostic devices, the company offers a diverse portfolio that includes critical care blood gas analyzers, point-of-care meters, and cell culture monitoring systems. With a global presence, Nova Biomedical is committed to enhancing patient care and accelerating biopharmaceutical development through cutting-edge technology and dedicated customer service.
Company Leadership



Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering. Our goal is to radically improve the lives of patients and industrialize drug discovery. Central to our mission is the Recursion Operating System, which combines an advanced infrastructure layer to generate what we believe is one of the world's largest and fastest-growing proprietary biological and chemical datasets. We combine that with the Recursion Map, a suite of custom software, algorithms and machine learning tools that we use to explore foundational biology unconstrained by human bias and navigate to new biological insights.
Company Leadership ML
DB
Beam Therapeutics is a biotechnology company developing precision genetic medicines using base editing. The company advances research and clinical programs aimed at providing durable treatments for serious diseases, supported by scientific leadership and drug development capabilities. Beam focuses on translating genome editing science into potential lifelong therapies for patients.
Company Leadership JE
AS
CB
GC